Document is current

Any future updates will be listed below

Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design

Crossref DOI link: https://doi.org/10.1007/s13300-020-00853-7

Published Online: 2020-06-23

Published Print: 2020-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark